Scholars International Journal of Biochemistry (SIJB)
Volume-4 | Issue-04 | 42-51
Review Article
Enzyme Vs Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia
Hadia Naseem, Iqra Kanwal, Muhammad Haseeb Anwar Tarar, Sabahat Irfan, Taiyyibah Basharat, Muhammad Adnan, Nabeela Fatima, Usman Ghani
Published : May 23, 2021
Abstract
Cancer is re-unowned by production of neoplastic cells. In cancer, un-developed cells are produced by bone marrow. After their entry into the blood normal cells are un-able to produce and cause anemia. Several oncogenes, including the p53, c-fms and Ras genes, can be activated by point mutations that change the amino acid sequence in the critical portion of protein. L-asparaginase is an enzyme which, by hydrolysis, produces aspartic acid and ammonia. It is used as medicine and in the food industry. It acts as a chemo-therapeutic agent to diagnose the ALL and lymphoproliferative syndrome. The level of Asparagine reduced in plasma decreases the formation of Deoxy ribonucleic acid and Ribonucleic acid. In ALL, asparaginase used in chemotherapy medicines for dealing the patients. it donates the important development in therapy results and helps achieve reform sullener approximately 90% of patients.